LymphedemaV1, Main, Exploration, bibRecord, 006439

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA

Identifieur interne : 006439 ( Main/Exploration ); précédent : 006438; suivant : 006440

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA

Auteurs : Jane M. Armer ; Bob R. Stewart ; Robin P. Shook

Source :

Journal of lymphoedema [ 1750-7235 ] ; 2009.

RBID : PMC:2826842

Abstract

Background

Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer.

Aims

This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques.

Methods

Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met.

Results

Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41–91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest.

Conclusions

This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826842

PubMed: 20182653
PubMed Central: 2826842

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA</title>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name>
</author>
<author><name sortKey="Shook, Robin P" sort="Shook, Robin P" uniqKey="Shook R" first="Robin P" last="Shook">Robin P. Shook</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">20182653</idno>
<idno type="pmc">2826842</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826842</idno>
<idno type="RBID">PMC:2826842</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">002828</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002828</idno>
<idno type="wicri:Area/Pmc/Curation">002827</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002827</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003846</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003846</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">002B57</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B57</idno>
<idno type="wicri:Area/PubMed/Curation">002B57</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B57</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002B57</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002B57</idno>
<idno type="wicri:Area/Ncbi/Merge">003933</idno>
<idno type="wicri:Area/Ncbi/Curation">003933</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003933</idno>
<idno type="wicri:doubleKey">1750-7235:2009:Armer J:month:post:breast</idno>
<idno type="wicri:Area/Main/Merge">006517</idno>
<idno type="wicri:Area/Main/Curation">006439</idno>
<idno type="wicri:Area/Main/Exploration">006439</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA</title>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name>
</author>
<author><name sortKey="Shook, Robin P" sort="Shook, Robin P" uniqKey="Shook R" first="Robin P" last="Shook">Robin P. Shook</name>
</author>
</analytic>
<series><title level="j">Journal of lymphoedema</title>
<idno type="ISSN">1750-7235</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer.</p>
</sec>
<sec id="S2"><title>Aims</title>
<p id="P2">This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques.</p>
</sec>
<sec sec-type="methods" id="S3"><title>Methods</title>
<p id="P3">Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met.</p>
</sec>
<sec id="S4"><title>Results</title>
<p id="P4">Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41–91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest.</p>
</sec>
<sec id="S5"><title>Conclusions</title>
<p id="P5">This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).</p>
</sec>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
<name sortKey="Shook, Robin P" sort="Shook, Robin P" uniqKey="Shook R" first="Robin P" last="Shook">Robin P. Shook</name>
<name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006439 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006439 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:2826842
   |texte=   30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20182653" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.